United Therapeutics (UTHR) Tax Rate (2009 - 2026)
United Therapeutics' (UTHR) quarterly Tax Rate came in at 10.65% in Q2 2026, down 1356.0% year-over-year from 0.85% in Q2 2025, and down 21.88% quarter-over-quarter from 13.63% in Q1 2026.
Analysis
United Therapeutics (UTHR) Tax Rate (2009 - 2026) Analysis & Trends
United Therapeutics has disclosed Tax Rate across 18 years of filings, most recently posting 10.65% for Q2 2026.
- In Q2 2026, Tax Rate fell 1356.0% year-over-year to 10.65%; the TTM figure through Jun 2026 stood at 16.66% (down 652.0% YoY), while the FY2025 annual figure was 22.12%, down 22.0% from the prior year.
- Tax Rate came in at 10.65% for Q2 2026 at United Therapeutics, down from 13.63% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 26.51% in Q4 2023 to a low of 10.65% in Q2 2026.
- Average Tax Rate over 5 years is 21.54%, with a median of 22.82% recorded in 2022.
- Year-over-year, Tax Rate surged 936 bps in 2022 and plunged 1356 bps in 2026.
- Over 5 years, Tax Rate stood at 26.12% in 2022, then climbed by 1 bps to 26.51% in 2023, then declined by 9 bps to 24.01% in 2024, then retreated by 25 bps to 17.95% in 2025, then plunged by 41 bps to 10.65% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 10.65% in Q2 2026, 13.63% in Q1 2026, and 17.95% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 10.65% |
| 10 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 10.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.65% |
| Mar 31, 2026 | 13.63% |
| Dec 31, 2025 | 17.95% |
| Sep 30, 2025 | 22.67% |
| Jun 30, 2025 | 24.22% |
| Mar 31, 2025 | 23.92% |
| Dec 31, 2024 | 24.01% |
| Sep 30, 2024 | 20.46% |
| Jun 30, 2024 | 21.73% |
| Mar 31, 2024 | 23.08% |
| Dec 31, 2023 | 26.51% |
| Sep 30, 2023 | 23.93% |
| Jun 30, 2023 | 22.67% |
| Mar 31, 2023 | 17.47% |
| Dec 31, 2022 | 26.12% |
| Sep 30, 2022 | 23.42% |
| Jun 30, 2022 | 22.97% |
| Mar 31, 2022 | 22.29% |
| Dec 31, 2021 | 20.14% |
| Sep 30, 2021 | 20.40% |